a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.
Ticker / NAME | Correlation To ETNB | 1D Price Change % | ||
---|---|---|---|---|
ETNB | 100% | -1.49% | ||
AKRO - ETNB | 63% Loosely correlated | -4.35% | ||
PLRX - ETNB | 48% Loosely correlated | -0.36% | ||
QSI - ETNB | 44% Loosely correlated | +2.06% | ||
MDGL - ETNB | 44% Loosely correlated | -7.05% | ||
NTLA - ETNB | 44% Loosely correlated | -3.24% | ||
More |